DaVita Inc. (NYSE:DVA) Receives Consensus Rating of “Hold” from Brokerages

Shares of DaVita Inc. (NYSE:DVA) have been assigned a consensus rating of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $216.50.

A number of research analysts recently weighed in on DVA shares. Barclays upped their price target on DaVita from $194.00 to $218.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft upgraded DaVita from a “hold” rating to a “buy” rating and boosted their price objective for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a research report on Monday, June 8th. UBS Group increased their target price on DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Finally, Truist Financial lifted their price target on shares of DaVita from $205.00 to $250.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th.

DaVita Stock Down 0.4%

NYSE:DVA traded down $1.06 during trading hours on Thursday, reaching $239.90. The company had a trading volume of 26,397 shares, compared to its average volume of 928,298. DaVita has a twelve month low of $101.00 and a twelve month high of $244.49. The firm has a market cap of $15.40 billion, a price-to-earnings ratio of 22.22, a P/E/G ratio of 0.78 and a beta of 0.88. The business’s 50-day simple moving average is $216.12 and its two-hundred day simple moving average is $171.76.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.54. The firm had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The business’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts predict that DaVita will post 15.07 earnings per share for the current year.

Insider Transactions at DaVita

In related news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider owned 109,194 shares in the company, valued at $22,756,029.60. This represents a 12.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the transaction, the chief financial officer owned 132,434 shares of the company’s stock, valued at $25,440,571.40. This trade represents a 27.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.90% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Root Financial Partners LLC grew its holdings in DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after buying an additional 105 shares in the last quarter. Caitlin John LLC bought a new position in DaVita during the 4th quarter valued at $34,000. Sankala Group LLC bought a new position in DaVita during the 4th quarter valued at $39,000. Canada Pension Plan Investment Board purchased a new position in DaVita during the 2nd quarter worth $43,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of DaVita in the 4th quarter worth $45,000. Institutional investors own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.